-+ 0.00%
-+ 0.00%
-+ 0.00%

Scinai Immunotherapeutics Announces The Establishment Of A U.S.-Based Subsidiary For Its Contract Development And Manufacturing Services

Benzinga·12/16/2024 14:26:49
Listen to the news

Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) ("Scinai" or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced today the establishment of a U.S.-based subsidiary for its Contract Development and Manufacturing Services. The new subsidiary, incorporated in Delaware, will operate under the name Scinai Bioservices Inc.